Sphingolipids – prominent molecules produced by bacteria in the gut microbiome – appear to ameliorate a problematic fatty liver, according to new Cornell nutrition research.
A new study from Weill Cornell Medicine researchers helps to explain the dynamics underlying liver damage that can accompany type 2 diabetes and obesity.
Personal sensing data could help monitor and alleviate stress among resident physicians, although privacy concerns over who sees the information and for what purposes must be addressed, according to collaborative research from Cornell Tech.
A specific toxin-producing gut bacteria may be responsible for both triggering the onset of multiple sclerosis (MS) and ongoing disease activity, according to a new study led by a team of researchers at Weill Cornell Medicine and NewYork-Presbyterian.
Sloan Program in Health Administration students will be working with five executives-in-residence. Sloan Program Associate Director Julie Carmalt says the students will have a range of mentoring and networking opportunities while learning from prominent leaders in the health care field.
Cornell professor Robert Howarth advised New York state senators last week to downsize the state’s natural gas pipeline system and to repeal laws that easily connect gas to new homes.
MBA candidates in the first cohort of Cornell's new BioEntrepreneurship Initiative will collaborate with doctoral researchers in the life sciences across Cornell. The program is designed to develop startup leaders and foster innovation in the life sciences.
Weill Cornell Medicine and Weill Bugando School of Medicine collaborate to strengthen medical education, health care and innovative global health research at both institutions.